Jedd Wolchok (Weill Cornell Medicine)
July 18, 2024 10:37 AM EDTUpdated 04:54 PM
Financing
R&D

Park­er In­sti­tute for Can­cer Im­munother­a­py in­vests an­oth­er $125M in­to re­search

Lei Lei Wu

News Reporter

The Park­er In­sti­tute for Can­cer Im­munother­a­py, a re­search net­work es­tab­lished by tech en­tre­pre­neur Sean Park­er, an­nounced a new $125 mil­lion in­vest­ment.

The lat­est in­vest­ment comes …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Se­cre­tive Tree­line Bio­sciences dis­clos­es $421M fi­nanc­ing in fil­ing

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the ...

Benev­o­len­tAI CEO is out af­ter less than a year on the job

FDA ap­proves Ab­b­Vie's 24-hour Parkin­son's in­fu­sion ther­a­py af­ter two CRLs

Sage shakes up se­nior man­age­ment, slash­es pipeline, sheds 33% of staff

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times